Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 3

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 3

Sponsor

Conditions

Leiomyoma 7Menorrhagia 4Myoma 3Myofibroma 2Uterine Neoplasms 1Pelvic Pain 1Patient Satisfaction 1Pain 1Metrorrhagia 1Hemorrhage 1Adenomyosis 1

Interventions

Terlipressin 4Sodium Chloride 4Vasopressins 3Uterine Myomectomy 3Uterine Artery Embolization 3carbetocin 2testo 1Tourniquets 1Saline Solution 1Radiofrequency Ablation 1Oxytocin 1Ofloxacin 1MoxDuo 1Misoprostol 1Magnesium Sulfate 1Hysteroscopy 1Ethamsylate 1Doxycycline 1Bupivacaine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Myoma × Uterine Artery Embolization × Clear all
NCT02163525 2025-09-30

Post Market TRUST - U.S.A. Study

Acessa Health, Inc.

Phase NA Completed
114 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT01563783 2023-02-01

TRUST

Acessa Health, Inc.

Phase NA Completed
84 enrolled

Leiomyoma, Menorrhagia, Myoma

NCT00995878 2018-01-12

The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.

Mayo Clinic

Phase 4 Completed
56 enrolled

Leiomyoma, Myoma, Pelvic Pain, Myofibroma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡